MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
Provided By GlobeNewswire
Last update: Nov 6, 2024
Tissue-based test volumes increase by 36%, liquid-based test volumes by 24%
Company raises 2024 revenue guidance to $87-89 million, representing 25% growth
Read more at globenewswire.comNASDAQ:MDXH (7/3/2025, 7:47:57 PM)
2.19
-0.02 (-0.82%)
Find more stocks in the Stock Screener
